共 50 条
- [21] Lipid-altering efficacy of switching to ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk patients with and without metabolic syndromeDIABETES & VASCULAR DISEASE RESEARCH, 2011, 8 (04) : 262 - 270Averna, MaurizioMissault, LucVaverkova, HelenaFarnier, MichelViigimaa, MargusDong, QianShah, ArvindJohnson-Levonas, Amy O.Taggart, WilliamBrudi, Philippe
- [22] A Comparison of Rosuvastatin Monotherapy and Rosuvastatin Plus Ezetimibe Combination Therapy in Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled TrialsCUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)Dadzie, Samuel K.Tabowei, GodfreyKaur, MandeepAhmed, SaeedThakur, AayushiKhreis, KhaldounBai, MonikaAmin, Adil
- [23] Ezetimibe/Simvastatin 10/20 mg versus Rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potencyLIPIDS IN HEALTH AND DISEASE, 2010, 9Viigimaa, MargusVaverkova, HelenaFarnier, MichelAverna, MaurizioMissault, LucHanson, Mary E.Dong, QianShah, ArvindBrudi, Philippe
- [24] Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy SubjectsDRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 2641 - 2652Ryu, HyunwookKim, Hyun ChulJeon, InseungJang, In-JinCho, Joo-YounKim, Kyung TaeOh, Jaeseong
- [25] Efficacy and Safety of Rosuvastatin 5 mg in Combination with Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia – A Phase 3 StudyCardiovascular Drugs and Therapy, 2010, 24 : 421 - 428Eli M. RothRobert S. RosensonDawn M. CarlsonSandra M. FukumotoCarolyn M. SetzeJames W. BlasettoNardev S. KhurmiJames C. StolzenbachLaura A. Williams
- [26] Efficacy and Safety of Rosuvastatin 5 mg in Combination with Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia - A Phase 3 StudyCARDIOVASCULAR DRUGS AND THERAPY, 2010, 24 (5-6) : 421 - 428Roth, Eli M.Rosenson, Robert S.Carlson, Dawn M.Fukumoto, Sandra M.Setze, Carolyn M.Blasetto, James W.Khurmi, Nardev S.Stolzenbach, James C.Williams, Laura A.
- [27] Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)Trials, 7Michael B ClearfieldJohn AmerenaJean-Pierre BassandHugo R Hernández GarcíaSam S MillerFroukje FM SosefMichael K PalmerBrian S Bryzinski
- [28] Efficacy and Safety of Atorvastatin 40 mg versus Rosuvastatin 20 mg in Patients with Type 2 Diabetes Mellitus and Previous Acute Coronary Syndrome: A Randomized Clinical TrialCLINICAL DIABETOLOGY, 2022, 11 (03): : 165 - 174Ebid, Abdel-Hameed Ibrahim MohamedGenina, Yasmine Magdy FahimAl-Jendy, Abdul-Majeed AbdulfattahEl-Sawy, Amira Mohamed
- [29] Effect of rosuvastatin 20 mg versus rosuvastatin 5 mg plus ezetimibe on statin side-effects in elderly patients with atherosclerotic cardiovascular disease: Rationale and design of a randomized, controlled SaveSAMS trialAMERICAN HEART JOURNAL, 2023, 261 : 45 - 50Cha, Jung-JoonHong, Soon JunKim, Ju HyeonLim, SubinJoo, Hyung JoonPark, Jae HyoungYu, Cheol WoongLee, Pil HyungLee, Seung WhanLee, Cheol WhanMoon, Jae YounLee, Jong-YoungKim, Jung-SunPark, Jae SukLee, KyounghoonLim, Sang YupNa, Jin OhCho, Jin-ManKim, Seok YeonLim, Do-Sun
- [30] Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS studyINTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (04) : 547 - 559Farnier, M.Averna, M.Missault, L.Vaverkova, H.Viigimaa, M.Massaad, R.Vandormael, K.Johnson-Levonas, A. O.Brudi, P.